1. Home
  2. KYMR vs RUSHB Comparison

KYMR vs RUSHB Comparison

Compare KYMR & RUSHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • RUSHB
  • Stock Information
  • Founded
  • KYMR 2015
  • RUSHB 1965
  • Country
  • KYMR United States
  • RUSHB United States
  • Employees
  • KYMR N/A
  • RUSHB N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • RUSHB Retail-Auto Dealers and Gas Stations
  • Sector
  • KYMR Health Care
  • RUSHB Consumer Discretionary
  • Exchange
  • KYMR Nasdaq
  • RUSHB Nasdaq
  • Market Cap
  • KYMR 4.3B
  • RUSHB 3.9B
  • IPO Year
  • KYMR 2020
  • RUSHB 1996
  • Fundamental
  • Price
  • KYMR $63.94
  • RUSHB $51.67
  • Analyst Decision
  • KYMR Strong Buy
  • RUSHB
  • Analyst Count
  • KYMR 19
  • RUSHB 0
  • Target Price
  • KYMR $68.95
  • RUSHB N/A
  • AVG Volume (30 Days)
  • KYMR 665.0K
  • RUSHB 35.2K
  • Earning Date
  • KYMR 11-04-2025
  • RUSHB 10-29-2025
  • Dividend Yield
  • KYMR N/A
  • RUSHB 1.44%
  • EPS Growth
  • KYMR N/A
  • RUSHB N/A
  • EPS
  • KYMR N/A
  • RUSHB 3.37
  • Revenue
  • KYMR $43,735,000.00
  • RUSHB $7,671,888,000.00
  • Revenue This Year
  • KYMR $60.88
  • RUSHB N/A
  • Revenue Next Year
  • KYMR N/A
  • RUSHB $6.33
  • P/E Ratio
  • KYMR N/A
  • RUSHB $14.14
  • Revenue Growth
  • KYMR N/A
  • RUSHB N/A
  • 52 Week Low
  • KYMR $19.45
  • RUSHB $48.96
  • 52 Week High
  • KYMR $65.69
  • RUSHB $61.55
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 63.12
  • RUSHB 39.97
  • Support Level
  • KYMR $56.75
  • RUSHB $49.03
  • Resistance Level
  • KYMR $61.21
  • RUSHB $50.91
  • Average True Range (ATR)
  • KYMR 3.12
  • RUSHB 1.48
  • MACD
  • KYMR -0.01
  • RUSHB -0.03
  • Stochastic Oscillator
  • KYMR 83.30
  • RUSHB 36.64

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About RUSHB Rush Enterprises Inc. Class B

Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.

Share on Social Networks: